com/reports/573951/ Company Analysis - Sun Pharmaceuticals Industries Ltd. Description: "Company Analysis assists individual investors‚ managers and companies in evaluating opportunities‚ trends‚ market innovations as well as in selecting appropriate information solutions in order to make effective investment decisions. The study covers information on the business structure‚ areas of operation‚ products and services offered by the company. It comprises SWOT analysis‚ Key Ratios‚ and financials that
Premium
Class of antibiotic w/c GABHS is very sensitive to: Penicillin - no reported resistance despite decades of use Single dose of IM Pencillin is effective Formulation for children because of less pain: combination of Penicillin G Benzathine and Penicillin G Procaine Oral penicillin is a good alternative - Penicillin V 4 Alternatives to Penicillin‚ if they have allergy: Erythromycin Cephalosporins Clindamycin Azithromycin What is the advantage of using penicillin as much as possible
Premium Schizophrenia Antipsychotic Penicillin
www.pwc.com/pharma2020 Pharma 2020: Supplying the future Which path will you take? Pharmaceuticals and Life Sciences Previous publications in this series include: Published in June 2007‚ this paper highlights a number of issues that will have a major bearing on the industry by 2020. The publication outlines the changes we believe will best help pharmaceutical companies realise the potential the future holds to enhance the value they provide to shareholders and society alike
Premium Supply chain management Supply chain
SWOT analysis From Wikipedia‚ the free encyclopedia Jump to: navigation‚ search A SWOT Analysis is a strategic planning tool used to evaluate the Strengths‚ Weaknesses‚ Opportunities‚ and Threats involved in a project or in a business venture or in any other situation of an organization or individual requiring a decision in pursuit of an objective. It involves monitoring the marketing environment internal and external to the organization or individual. The technique is credited to Albert Humphrey
Premium SWOT analysis Strategic management Management
Purdue Pharma is a pharmaceutical company that created the drug called OxyContin‚ which is widely credited for having launched the opioid epidemic that has come to affect several Canadian regardless of socioeconomic status. Canada being the world’s second-largest per capita per consumer of opioids behind the United States which is rooted in over-prescribing. The rise of OxyContin was initially thought to be a beneficial one because it was advertised as a pain reliever was produced with a slow-release
Premium Drug Drug addiction Illegal drug trade
Term 2‚ 2010/11 MGMT003 Business‚ Government and Society (BGS) Instructor: Dr. Gilbert Tan An analysis of Case 29: Big Pharma’s Marketing Tactics Introduction The Big Pharma controversy is about the wide-scale marketing malpractices used by big pharmaceutical companies in America which resulted in a series of negative implications on consumers. It revolves around pharmaceutical companies‚ government regulators‚ health professionals (or “unprofessional”)‚ market consumers and the medical watchdogs
Premium Pharmaceutical industry Pharmacology Drug development
drugs”‚ it seems that in today’s modern quest for perfect health‚ or at least prolonged health‚ the drug industries in the United States (also addressed as Big Pharma) compete to find and sell the next big drug. These drug industries do not wage war against drugs‚ instead a “war for drugs”. Nevertheless‚ what kind of drug is Big Pharma after? According to Sonia Shah‚ investigative journalist
Premium Drug United States Drug addiction
constantly replenish the supply of potential blockbusters requires a consistent and dedicated approach to drug R&D. However no longer is inhouse research expertise sufficient. 2 Chart 1 Decreased R&D Productivity (source: FDA - PhRMA 2007) Pharma R&D Investments (Billion USD) 120 New medicines Approved by FDA 60 100 50 80 40 60 30 40 20 20 10 0 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 YEAR 0 To fill this pipeline gap‚ pharmaceutical
Premium Net present value Discounted cash flow Cash flow
PHARMA-SAYA INNOVATIVE SOLUTIONS‚ INC. Bringing better smiles that build better lives 259 CEU Bldg.‚ Sen. Gil Puyat Ave.‚ Makati City Phils. OUR MOTTO Bringing better smiles that build better lives. OUR MISSION-VISION STATEMENT PSIS is a Philippine company that values one of the most cognizant traits of the Filipino men‚ being gleeful‚ where the connotation that the SMILE is the most powerful weapon and shield of the Filipino started. The company is dedicated to bring better
Free Metro Manila Manila Toothpaste
REPORT 2009-10 Torrent Pharmaceuticals Limited 2 N TE CO N TS Corporate Information 02 Notice 03 Directors’ Report 06 Report on Corporate Governance 14 Auditors’ Report 24 Audited Financial Statements 28 Management Discussion and Analysis 55 Consolidated Financial Statements 66 37th ANNUAL REPORT 2009-10 3 CORPORATE INFORMATION DIRECTORS Sudhir Mehta Chairman REGISTERED OFFICE Torrent House‚ Markand Bhatt S. H. Bhojani Dr. Prasanna Chandra Kiran Karnik Sanjay Lalbhai
Premium Board of directors Corporate governance